Abstract:Objective: The aim of this research is to synthesize and evaluate beta-amyloid (A beta) binding probes for early diagnosis of Alzheimer's disease (AD). Methods: We designed and synthesized two new fluorine tag Indanone derivatives (compounds a and b), and then based on the platform of ultra-high-performance liquid chromatography-mass spectrometry for its affinity with beta-amyloid (A beta) protein determination, and use of compounds a and b solution as dyes for AD brain tissue staining in vitro. To evaluate the lipid solubility and stability of the drug, the lipid-water partition coefficient was determined using n-octanol as the lipid phase, and the stability of compound b was tested in vitro to mimic the in vivo environment. Results: Both compounds a and b exhibit high affinity for binding to A beta. The Kd values of compound a for A beta 1-40 and A beta 1-42 were found to be 467.40 +/- 63.26, and 227.57 +/- 19.08 nmol/L, respectively. Similarly, the Kd values of compound b for A beta 1-40 and A beta 1-42 were 438.13 +/- 26.77 and 167.27 +/- 23.70 nmol/L, respectively. In the staining experiment of human brain slices of AD, both compounds a and b were found to bind to A beta plaques, and their staining effect was stronger than positive control (0.1 % ThS). In the lipid-water partition coefficient experiment, compound a and compound b exhibited logP values of 0.84 and 1.85, respectively, indicating good lipid solubility. In the in vitro stability experiment, compound b exhibited a concentration of 74.79 %, 80.47 %, and 70.00 % after incubation in liver, brain homogenate, and blood, respectively. Conclusion: We have successfully designed and synthesized two probes labeled with fluoride that can be used for diagnosing AD. These probes have a high affinity for A beta protein and good lipid solubility. As A contrast agent based on A beta protein, compound b showed greater potential than compound a.

Multi‐fluorine Labeled Indanone Derivatives As Potential MRI Imaging Probes for Β‐amyloid Plaques

Novel Indanone Derivatives As Potential Imaging Probes for Β‐amyloid Plaques in the Brain

Synthesis and in Vitro Evaluation of Novel Indanone Derivatives Targeting Β-Amyloid

6-Methoxy-indanone Derivatives As Potential Probes for Β-Amyloid Plaques in Alzheimer's Disease

Novel Anilinophthalimide Derivatives As Potential Probes for Beta-Amyloid Plaque in the Brain

Radioiodinated Benzimidazole Derivatives As Single Photon Emission Computed Tomography Probes for Imaging of Β-Amyloid Plaques in Alzheimer's Disease

Novel Imaging Agents for Β-Amyloid Plaque Based on the N-benzoylindole Core.

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques.

(E)-5-Styryl-1h-Indole And (E)-6-Styrylquinoline Derivatives Serve As Probes For Beta-Amyloid Plaques

Synthesis and Biological Evaluation of 18F-Labled 2-Phenylindole Derivatives As PET Imaging Probes for Β-Amyloid Plaques

Naphthofuran Derivatives As Potential Imaging Agents for Β-Amyloid Plaques in the Brain

(99M)tc-Labeled Dibenzylideneacetone Derivatives As Potential SPECT Probes for in Vivo Imaging of Β-Amyloid Plaque.

Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation and in Vivo Imaging.

Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo

18F-Labeled Benzyldiamine Derivatives As Novel Flexible Probes for Positron Emission Tomography of Cerebral Β-Amyloid Plaques.

Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

Al18F-NODA Benzothiazole Derivatives As Imaging Agents for Cerebrovascular Amyloid in Cerebral Amyloid Angiopathy

Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer’s disease